ALKBH5 inhibitors belong to a class of chemicals that are designed to target and inhibit the activity of the AlkB homolog 5 (ALKBH5) protein. ALKBH5 is an enzyme that is part of the AlkB family of dioxygenases, which are involved in the oxidative demethylation of N-methylated nucleic acids. Specifically, ALKBH5 demethylates N^6-methyladenosine (m^6A), a modification found within RNA molecules. This modification is a dynamic and reversible process that can affect RNA stability, splicing, export, localization, and translation, thus playing a crucial role in the regulation of gene expression. Inhibitors of ALKBH5 are chemical compounds that interfere with the catalytic activity of this enzyme, blocking its ability to demethylate m^6A on RNA substrates. By doing so, these inhibitors can alter the methylation landscape of RNA in cells where ALKBH5 is active.
The development and study of ALKBH5 inhibitors are grounded in biochemistry and molecular biology, focusing on the interaction between the inhibitor and the active site of the ALKBH5 enzyme. These inhibitors are often small molecules that mimic the natural substrates of the enzyme or bind to its active site, thus preventing it from interacting with its actual RNA targets. The design of such inhibitors may involve structure-activity relationship (SAR) studies to optimize their binding affinity and selectivity toward ALKBH5.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Meclofenamic Acid | 644-62-2 | sc-211780 | 5 mg | $402.00 | ||
A chemical known to inhibit FTO, another m6A demethylase. May have potential off-target effects on ALKBH5. | ||||||
Dimethyloxaloylglycine (DMOG) | 89464-63-1 | sc-200755 sc-200755A sc-200755B sc-200755C | 10 mg 50 mg 100 mg 500 mg | $84.00 $301.00 $374.00 $779.00 | 25 | |
Prolyl hydroxylase inhibitor; while primarily targeting HIF prolyl hydroxylases, its broad demethylase inhibition can include ALKBH5. | ||||||
Deferoxamine | 70-51-9 | sc-507390 | 5 mg | $255.00 | ||
Iron chelator. Since ALKBH5's demethylase activity requires iron, iron chelation can reduce its activity. | ||||||
2,4-Pyridinedicarboxylic acid monohydrate | 207671-42-9 | sc-225693 | 1 g | $29.00 | ||
Another inhibitor of prolyl hydroxylases, which can show a broad inhibition over 2-oxoglutarate-dependent dioxygenases like ALKBH5. | ||||||
JIB 04 | 199596-05-9 | sc-397040 | 20 mg | $177.00 | ||
A pan-selective Jumonji histone demethylase inhibitor. Might affect ALKBH5 due to its influence on demethylase enzymes. | ||||||
Pyridoxal Isonicotinoyl Hydrazone | 737-86-0 | sc-204192 | 50 mg | $265.00 | 9 | |
Iron chelator, can interfere with the iron-dependent catalytic activity of ALKBH5. | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
A selective Jumonji H3K27 demethylase inhibitor. Its broader effects on RNA demethylases, including ALKBH5, need exploration. | ||||||